Filter

21 - 30 of 328 Results

  • How Does the Federal Government Monitor Vaccine Safety?

    Issue Brief

    This issue brief gives an overview of the main systems used by the federal government to track vaccine safety and adverse events following vaccinations. The brief reviews the history of federal vaccine safety systems, describes the key systems and their strengths and limitations, and also discusses how vaccine safety issues have become the subject of more scrutiny under the Trump administration.

  • Shifts in Funding Priorities and Vaccine Guidance Contribute to Safety Myths, Plus Reactions to Ruling in U.S. v. Skrmetti — The Monitor

    Feature

    This volume examines how the cancellation of contracts to develop a bird flu vaccine and unfounded claims by new vaccine advisors reflect persistent myths about the safety of mRNA technology. It also explores false claims linking COVID-19 vaccines to miscarriage and analyzes how reactions to a Supreme Court ruling on gender-affirming care for minors highlights misconceptions and inflammatory language.

  • Flawed Report Aims to Undercut Established Research on Abortion Pill Safety, Plus How a Federal Initiative to Study Autism May Overemphasize Environmental Toxins — The Monitor

    Feature

    This volume highlights how a report criticized for flawed methodology is influencing renewed efforts to restrict access to mifepristone; a federal plan to study the causes of autism that could be contributing to stigma by over-emphasizing environmental toxins; and the resurgence of false claims about fetal tissue in vaccines.

  • Federal Vaccine Advisory Committees: Roles and Current Issues

    Issue Brief

    This brief describes four key federal vaccine advisory committees and discusses policy issues and questions they currently face. The four committees are the Vaccines and Related Biological Products Advisory Committee (VRBPAC) at the Food and Drug Administration (FDA); the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC); the National Vaccine Advisory Committee (NVAC) at the Department of Health and Human Services (HHS); and the Advisory Commission on Childhood Vaccines (ACCV) at HHS.

  • A quote card of Josh Michaud's Quick Take reads: "Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years. ... such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe. "

    How Could FDA’s New Guidance Affect COVID-19 Vaccination Coverage in the U.S.?

    Quick Take

    Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years...such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.

  • Public Trust in Vaccine Information, Misrepresented Vaccine Studies, and HIV and PrEP Stigma — The Monitor

    Feature

    This volume examines findings about trusted sources of vaccine information from the latest KFF Tracking Poll on Health Information and Trust. It also explores how the misrepresentation of studies and policy developments contribute to health narratives around vaccines, HIV and PrEP. Lastly, it summarizes new research on the use of generative AI to counteract vaccine misinformation.

  • In his latest column, KFF’s President and CEO Drew Altman discusses how the low levels of trust in the CDC and FDA today seen in KFF’s recent survey findings present a danger should the country face another epidemic.

    The Sad State of Trust in the CDC and FDA

    From Drew Altman

    In his latest column, KFF’s President and CEO Drew Altman discusses how the low levels of trust in the CDC and FDA today seen in KFF’s recent survey findings present a danger should the country face another epidemic.

  • KFF Tracking Poll on Health Information and Trust: Vaccine Safety and Trust

    Poll Finding

    As the Trump administration overhauls government health agencies, partisan trust in these agencies on vaccines has shifted and few express confidence in their ability to carry out key tasks. Most adults are confident in the safety of routine vaccines, but the COVID-19 vaccines remain polarizing with many uncertain about false claims regarding mRNA technology.